Multiple sclerosis (MS) is a demyelinating disease of the central nervous system in which autoimmune T lymphocytes reacting with myelin antigens are believed to play a pathogenic role. Since HLA binding is involved in the selection of T cell responses, we have examined PLP peptide binding to HLA DR2, an HLA allele frequently found in MS patients. Both PLP 40–60 and PLP 89–106 show significant, high affinity binding to HLA DR2. We then tested whether responses to PLP peptides 40–60 and 89–106 are elevated in multiple sclerosis patients compared to matched controls. We also analysed T cell responses to MBP 87–106, which is considered to be the immunodominant region of MBP in humans. Here we demonstrate heterogenous T cell responses to PLP 40–60, PLP 89–106 and MBP 87–106 in both MS patients and controls. The overall number of TCL and the HLA restriction of those TCL did not vary significantly in the two groups. PLP 40–60 specific cytolytic TCL were increased in MS patients, whereas healthy controls had increased percentages of cytolytic TCL responding to PLP 89–106 and MBP 87–106. Although the data presented here shows heterogenous responses in T cell numbers, differences in numbers and specificity of cytolytic cells could be involved in the pathogenesis of autoimmune demyelinating disease.
1 Martin R, McFarland HF, McFarlin DE. (1992) Immunological aspects of demyelinating diseases. Ann Rev Immunol10: 153–187.
2.
2 Zamvil SS, Steinman L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol8: 579–621.
3.
3 Lees MB, Macklin WB. (1988) Myelin proteolipid protein. In: Marangos PJ, Campbell IC, Cohen RM eds. Neuronal and Glial Proteins: Structure, Function and Clinical Application.Orlando: Academic Press, pp 267–294.
4.
4 Selmaj K et al. (1991) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol147: 1522–1529.
5.
5 Yamamura T et al. (1986) Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J Neuroimmunol12: 143–153.
6.
6 Yoshimura T et al. (1985) Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein. J Neurol Sci69: 47–58.
7.
7 Trotter JL et al. (1987) Myelin proteolipid protein induces demyelinating disease in mice. J Neurol Sci79: 173–188.
8.
8 Puckett C et al. (1987) Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J Neurosci Res18: 511–518.
9.
9 Agrawal HC, Agrawal D. (1991) Proteolipid protein and DM-20 are synthesized by Schwann cells, present in myelin membrane, but they are not fatty acylated. Neurochem Res16: 855–858.
10.
10 Trotter JL, Lieberman L, Margolis FL, Agrawal HC. (1981) Radioimmunoassay for central nervous system myelin-specific proteolipid protein. J Neurochem36: 1256–1262.
11.
11 Kennedy MK et al. (1990) Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J Immunol144: 909–915.
12.
12 Tabira T. (1988) Autoimmune demyelination in the central nervous system. Ann NY Acad Sci540: 187–201.
13.
13 Johnson D et al. (1986) Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J Neuroimmunol13: 99–108.
14.
14 Ota K et al. (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature346: 183–187.
15.
15 Kerlero de Rosbo N et al. (1993) Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest92: 2602–2608.
16.
16 Hafler DA, Benjamin DS, Burks J, Weiner HL. (1987) Myelin basic protein and proteolipid protein reactivity of brain-and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J Immunol139: 68–72.
17.
17 Trotter JL, Hickey WF, van der Veen RC, Sulze L. (1991) Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J Neuroimmunol33: 55–62.
18.
18 Sun JB et al. (1991) Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol21: 1461–1468.
19.
19 Pelfrey CM, Trotter JL, Tranquill LR, McFarland HF. (1993) Identification of a novel T cell epitope of human proteolipid protein (residues 40–60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. J Neuroimmunol46: 33–42.
20.
20 Zhang J et al. (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med179: 973–984.
21.
21 Pelfrey CM, Trotter JL, Tranquill LR, McFarland HF. (1994) Identification of a second T cell epitope of human proteolipid protein (residues 89–106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. J Neuroimmunol53: 153–161.
22.
22 Chou YK et al. (1992) Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol38: 105–113.
23.
23 Martin R et al. (1990) Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol145: 540–548.
24.
24 Diehl AJ, Schaich M, Budzinski RM, Stoffel W. (1986) Individual exons encode the integral membrane domains of human proteolipid protein. Proc Natl Acad Sci USA83: 9807–9811.
25.
25 Fritz R, McFarlin DE. (1989) Encephalitogenic epitopes of myelin basic protein. In: Secarz E ed. Chemical Immunology, 46th ed. Basel: Karger, p 101.
26.
26 Margalit H et al. (1987) Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol138: 2213–2229.
27.
27 Sette A et al. (1989) Structural analysis of peptides capable of binding to more than one Ia antigen. J Immunol142: 35–40.
28.
28 Greer JM et al. (1996) Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol156: 371–379.
29.
29 Vogt AB et al. (1994) Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol153: 1665–1673.
30.
30 Kropshof er H, Bohlinger I, Max H, Kalbacher H. (1991) Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets. Biochemistry30: 9177–9187.
31.
31 Kropshof er H et al. (1992) Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.J Exp Med175: 1799–1803.
32.
32 Jaraquemada D et al. (1990) HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J Immunol145: 2880–2885.
34 Malcherek G et al. (1993) Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int Immunol5: 1229–1237.
35.
35 Rammensee HG, Falk K, Rotzschke O. (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol11: 213–244.
36.
36 Frick E. (1989) Immunological studies of the pathogenesis of multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides. Acta Neurol Scand79: 1–11.
37.
37 Rayner DC, Petrycky-Cox LD, Diocee M, Rector E. (1993) Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumour necrosis factor-independent nucleolytic mechanism. Immunology78: 273–278.
38.
38 Markovic-Plese S et al. (1995) T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol155: 982–992.
39.
39 Valli A et al. (1993) Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest91: 616–628.
40.
40 Jingwu Z et al. (1992) Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol32: 330–338.
41.
41 Link J et al. (1994) Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta. J Neuroimmunol49: 9–18.
42.
42 Martin R et al. (1993) Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis. Ann Neurol34: 524–535.
43.
43 Weber WEJ, Vandermeeren MMPP, Raus JCM, Buurman WA. (1989) Human myelin basic protein-specific cytolytic T lymphocyte clones are functionally restricted by HLA class II gene products. Cell Immunol120: 145–153.
44.
44 Pelfrey CM et al. (1995) Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J Immunol154: 6191–6202.
45.
45 Kawai K, Zweiman B. (1990) Characteristics of in vitro cytotoxic effects of myelin basic protein-reactive T cell lines on syngeneic oligodendrocytes. J Neuroimmunol26: 57–67.
46.
46 Lyman WD et al. (1988) Quantitation of antigen-specific T-cell-induced demyelination in vitro. J Neuroimmunol17: 175–180.
47.
47 Selmaj K, Bradbury K, Champman J. (1988) Multiple sclerosis: effects of activated T-lymphocyte-derived products on organ cultures of nervous tissue. J Neuroimmunol18: 255–268.
48.
48 Halachmi E et al. (1992) Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). I. Cell detachment and lysis induced by encephalitogenic CD4+ T lympocytes. J Autoimmun5: 411–425.
49.
49 Stalder T, Hahn S, Erb P. (1994) Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol152: 1127–1133.
50.
50 Ruijs TC et al. (1990) Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I-restricted lymphocytes. J Neuroimmunol27: 89–97.
51.
51 Tsuchida T et al. (1994) Autoreactive CD8+ T cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci USA91: 10859–10863.
